Wu Xiaofang, Mimms Remy, Lima Roberta, Peters-Hall Jennifer, Rose Mary C, Peña Maria T
Center for Genetic Medicine Research, Children's National Medical Center, 111 Michigan Ave NW, Washington, DC 20010, USA.
Arch Otolaryngol Head Neck Surg. 2012 Apr;138(4):389-97. doi: 10.1001/archoto.2012.155.
Microarray analyses of sinus mucosa in pediatric patients with chronic rhinosinusitis (CRS) have recently demonstrated increased messenger RNA expression of the inflammatory chemokines CXCL5 and CXCL13 and of the innate immune mediators β-defensin 1 (DEFB1), serum amyloid A2 (SAA2), and serpin B4. The objectives of this study were to determine whether these gene products were expressed at the protein level in pediatric sinus mucosa and to determine their localization.
Immunohistochemical analysis was used to identify protein expression and cellular localization of CXCL5, CXCL13, DEFB1, SAA2, and serpin B4. Coimmunofluorescence staining of inflammatory cells was performed to further evaluate expression of CXCL5 and CXCL13.
Pediatric tertiary care facility.
Fifteen children with CRS who underwent endoscopic sinus surgery and 8 children who underwent craniofacial or neurosurgical procedures for abnormalities other than sinusitis.
Protein expression and cellular localization of CXCL5, CXCL13, DEFB1, SAA2, and serpin B4 in pediatric sinus mucosa.
Ciliated and basal cells in the pseudostratified epithelium stained positively for the 5 mediators examined in both cohorts. Except for serpin B4, goblet cells did not stain for any mediators in either cohort. Glandular cells stained positively for all 5 mediators in both cohorts. Coimmunofluorescence staining of inflammatory cells showed that CXCL13 was expressed in macrophages, T and B cells but not in neutrophils. CXCL5 was detected only in T cells.
CXCL5, CXCL13, DEFB1, SAA2, and serpin B4 were expressed at the protein level in the sinus mucosa of controls and pediatric patients with CRS and exhibited cell-specific localization. These mediators, not typically associated with pediatric CRS, may be involved in the inflammatory response and mucus hypersecretion seen in pediatric CRS.
近期对慢性鼻 - 鼻窦炎(CRS)患儿鼻窦黏膜进行的微阵列分析显示,炎症趋化因子CXCL5和CXCL13以及固有免疫介质β - 防御素1(DEFB1)、血清淀粉样蛋白A2(SAA2)和丝氨酸蛋白酶抑制剂B4的信使核糖核酸表达增加。本研究的目的是确定这些基因产物在儿童鼻窦黏膜中是否在蛋白质水平表达及其定位。
采用免疫组织化学分析来鉴定CXCL5、CXCL13、DEFB1、SAA2和丝氨酸蛋白酶抑制剂B4的蛋白质表达及细胞定位。对炎症细胞进行共免疫荧光染色以进一步评估CXCL5和CXCL13的表达。
儿科三级护理机构。
15例接受鼻内镜鼻窦手术的CRS患儿以及8例因鼻窦炎以外的异常接受颅面或神经外科手术的患儿。
儿童鼻窦黏膜中CXCL5、CXCL13、DEFB1、SAA2和丝氨酸蛋白酶抑制剂B4的蛋白质表达及细胞定位。
在两个队列中,假复层上皮中的纤毛细胞和基底细胞对所检测的5种介质均呈阳性染色。除丝氨酸蛋白酶抑制剂B4外,两个队列中的杯状细胞对任何介质均无染色。两个队列中的腺细胞对所有5种介质均呈阳性染色。炎症细胞的共免疫荧光染色显示,CXCL13在巨噬细胞、T细胞和B细胞中表达,但在中性粒细胞中不表达。CXCL5仅在T细胞中检测到。
CXCL5、CXCL13、DEFB1、SAA2和丝氨酸蛋白酶抑制剂B4在对照组和CRS患儿的鼻窦黏膜中在蛋白质水平表达,并表现出细胞特异性定位。这些通常与儿童CRS无关的介质可能参与了儿童CRS中所见的炎症反应和黏液分泌亢进。